Compare Cardinal Health Inc (CAH) vs IAC/Interactivecorp (PPLI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Cardinal Health Inc vs IAC/Interactivecorp — how do they compare? Cardinal Health Inc trades at $229.02 (market cap $53.89B), while IAC/Interactivecorp trades at $45.82 (market cap $3.37B). The key difference: Cardinal Health Inc is far larger — about 16× IAC/Interactivecorp's market cap, and Cardinal Health Inc pays a 0.89% dividend while IAC/Interactivecorp pays none. Which is the better fit depends on your goals.
| CAH | PPLI | |
|---|---|---|
Market Cap | $53.89B | $3.37B |
Sector | Health | Media |
52-Week High | $239.71 | $47.62 |
52-Week Low | $146.04 | $31.52 |
Enterprise Value | $58.87B | $3.68B |
Dividend Yield | 0.89% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Cardinal Health (CAH) trades at $233.66, down 0.91% in the last session, with a bullish technical signal from moving averages and strong analyst support. The company has consistently beaten earnings estimates in recent quarters, with Q1 2026 EPS of $3.17 surpassing expectations. Revenue reached $222.58 billion in 2025, though net margins remain thin at 0.62%. Recent news highlights growth potential in medical supplies, with earnings results for fiscal 2026 due August 11.
The outlook for CAH is positive, driven by earnings momentum and sector tailwinds, but risks include high leverage with debt-to-asset ratio at 16.09% and competitive pressures. Analyst consensus is bullish with a $248 price target, suggesting 6% upside. Investors should weigh solid operational cash flow against negative shareholder equity and investing outflows.
PPLI trades at $45.89, down 1.31% today, with a mixed technical outlook showing bullish moving averages but neutral oscillators. The company reported a net loss of $104.03M in 2025, missing earnings expectations for three consecutive quarters. Recent news indicates potential acquisition interest from MGM Resorts, adding speculative momentum. The stock's valuation metrics show a low P/B of 0.75 but a high P/E of 28.17, reflecting investor uncertainty about profitability.
The outlook is cautiously optimistic due to strong analyst support (63.64% buy ratings) and a $55.40 consensus price target, suggesting 21% upside. However, persistent earnings misses, negative cash flow trends, and high debt levels pose significant risks. Revenue decline from $5.2B in 2022 to $2.4B in 2025 highlights operational challenges that need addressing for sustained recovery.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Cardinal Health Inc
Cardinal Health is a leading pharmaceutical wholesaler, engaged in the sourcing and distribution of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail-order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and McKesson, the three compose well over 90% of the U.S. pharmaceutical wholesale industry. Cardinal Health also supplies medical-surgical products and equipment to healthcare facilities in North America, Europe, and Asia.
Read more on CAH →About IAC/Interactivecorp
IAC Inc is an Internet media company with segments that include Angi (47% of total revenue), Dotdash (10%), search (24%), and emerging and other (19%). The firm spun off the narrow-moat dating app provider Match Group in second-quarter 2020 and the no-moat video software provider Vimeo in second-quarter 2021.
Read more on PPLI →
